Literature DB >> 16278650

Glycomics: an integrated systems approach to structure-function relationships of glycans.

Rahul Raman1, S Raguram, Ganesh Venkataraman, James C Paulson, Ram Sasisekharan.   

Abstract

In comparison with genomics and proteomics, the advancement of glycomics has faced unique challenges in the pursuit of developing analytical and biochemical tools and biological readouts to investigate glycan structure-function relationships. Glycans are more diverse in terms of chemical structure and information density than are DNA and proteins. This diversity arises from glycans' complex nontemplate-based biosynthesis, which involves several enzymes and isoforms of these enzymes. Consequently, glycans are expressed as an 'ensemble' of structures that mediate function. Moreover, unlike protein-protein interactions, which can be generally viewed as 'digital' in regulating function, glycan-protein interactions impinge on biological functions in a more 'analog' fashion that can in turn 'fine-tune' a biological response. This fine-tuning by glycans is achieved through the graded affinity, avidity and multivalency of their interactions. Given the importance of glycomics, this review focuses on areas of technologies and the importance of developing a bioinformatics platform to integrate the diverse datasets generated using the different technologies to allow a systems approach to glycan structure-function relationships.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278650     DOI: 10.1038/nmeth807

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  101 in total

Review 1.  Glycans as receptors for influenza pathogenesis.

Authors:  Karthik Viswanathan; Aarthi Chandrasekaran; Aravind Srinivasan; Rahul Raman; V Sasisekharan; Ram Sasisekharan
Journal:  Glycoconj J       Date:  2010-08-24       Impact factor: 2.916

Review 2.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

3.  Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism.

Authors:  Niraj R Mehta; Thien Nguyen; John W Bullen; John W Griffin; Ronald L Schnaar
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

4.  Origins of stochasticity and burstiness in high-dimensional biochemical networks.

Authors:  Simon Rosenfeld
Journal:  EURASIP J Bioinform Syst Biol       Date:  2008-10-16

5.  Analysis of glycosaminoglycans in stem cell glycomics.

Authors:  Boyangzi Li; Haiying Liu; Zhenqing Zhang; Hope E Stansfield; Jonathan S Dordick; Robert J Linhardt
Journal:  Methods Mol Biol       Date:  2011

6.  Glycomic profiling of invasive and non-invasive breast cancer cells.

Authors:  John A Goetz; Yehia Mechref; Pilsoo Kang; Meei-Huey Jeng; Milos V Novotny
Journal:  Glycoconj J       Date:  2008-08-28       Impact factor: 2.916

7.  Serum glycan signatures of gastric cancer.

Authors:  Sureyya Ozcan; Donald A Barkauskas; L Renee Ruhaak; Javier Torres; Cara L Cooke; Hyun Joo An; Serenus Hua; Cynthia C Williams; Lauren M Dimapasoc; Jae Han Kim; Margarita Camorlinga-Ponce; David Rocke; Carlito B Lebrilla; Jay V Solnick
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

8.  Quantifiable fluorescent glycan microarrays.

Authors:  Xuezheng Song; Baoyun Xia; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-09-01       Impact factor: 2.916

9.  Cryogenic IR spectroscopy combined with ion mobility spectrometry for the analysis of human milk oligosaccharides.

Authors:  Neelam Khanal; Chiara Masellis; Michael Z Kamrath; David E Clemmer; Thomas R Rizzo
Journal:  Analyst       Date:  2018-04-16       Impact factor: 4.616

10.  Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones.

Authors:  Audrey Arfi; Magali Richard; Christelle Gandolphe; Daniel Scherman
Journal:  J Inherit Metab Dis       Date:  2010-02       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.